Cargando…
Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma
The determination of biomarkers in the blood specific for lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) is crucial for the selection of effective treatment strategies and the prediction of prognosis. The purpose of the present study was to analyze the differentially expressed ge...
Autores principales: | Cao, Bingji, Wang, Pengyu, Gu, Lina, Liu, Junfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882885/ https://www.ncbi.nlm.nih.gov/pubmed/33664813 http://dx.doi.org/10.3892/ol.2021.12510 |
Ejemplares similares
-
Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021) -
Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods
por: Chen, Joe W., et al.
Publicado: (2021) -
Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling
por: Lu, Chaojing, et al.
Publicado: (2016) -
Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
por: Yao, Yan, et al.
Publicado: (2021) -
Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC)
por: Zhang, Lemeng, et al.
Publicado: (2020)